Steven DuBois, MD, MS

Director, Experimental Therapeutics
Associate Professor of Pediatrics, Harvard Medical School
Office Phone: 617-632-5460
Appointment Phone: 888-733-4662 (new); 617-632-3270 (established)
Fax: 617-632-5710
Preferred Contact Method: office phone

General

Treatment Centers
Disciplines
Pediatric Hematology/Oncology
Clinical Interests
Novel agents, Phase 1 clinical trials, Ewing sarcoma, Neuroblastoma, Other pediatric solid tumors

Location

Dana-Farber Cancer Institute
450 Brookline Avenue
Boston, MA  02215

Background

Board Certifications
Pediatric Hematology/Oncology, 2009
Fellowships
Boston Children's Hospital/Dana-Farber Cancer Institute, Pediatric Hematology/Oncology, 2007
Residency
University of California, San Francisco School of Medicine, Pediatrics, 2003
Internships
University of California, San Francisco School of Medicine, Pediatrics, 2001
Medical School
University of California, San Francisco School of Medicine, 2000
Biography

Dr. DuBois is director of experimental therapeutics at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center. He is a pediatric oncologist with an active clinical and translational research program focused on patients with advanced neuroblastoma and Ewing sarcoma. He conducts phase 1 and 2 clinical trials of novel targeted agents. His clinical practice focuses on providing outstanding team-based care for children and young adults with solid cancers.

Research
Dr. Steven DuBois directs the Experimental Therapeutics Program and the Advancing Childhood Cancer Therapies (ACCT) clinic, which offers novel early phase clinical trials for children with relapsed or refractory cancer.  Learn more about ACCT.

Video: Meet Steven DuBois

Bringing new treatments to children with cancer

Dr. Steven DuBois oversees testing of new treatments for pediatric patients at Dana-Farber/Boston Children’s. He is working to increase the number of clinical trials available for children and young adults. He specializes in caring for patients with solid tumors such as Ewing sarcoma and neuroblastoma.

Appointments & Second Opinions

Speak with one of our New Patient Coordinators to schedule an appointment, refer a patient or request a second opinion. In urgent cases, we can typically see new patients within 24 hours.

Clinical Trials

Search our wide range of clinical trials, including novel therapies, immunotherapy and personalized therapy.callout bg

Harvard Medical Affiliate

HMS Callout FAD 

As a teaching affiliate of Harvard Medical School, our physicians are passing on their expertise to the next generation of pediatric hematologists and oncologists.